20

October 20, 2014

Natural product-based therapy for Alzhemer’s disease: Diallyl trisulfide, a compound derived from Garlic, decreases Tau expression via up regulation of its target gene, 20/October/2014, 16.28

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., Natural product-based therapy for Alzhemer’s disease: Diallyl trisulfide, a compound derived from Garlic, decreases Tau […]
October 20, 2014

MiRNA-based therapy for Cancer: MiRNA-346 increases the expression of the guardian of the genome p53 via down regulation of its target gene, 20/October/2014, 16.19

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, MiRNA-based therapy for Cancer: MiRNA-346 increases the expression of the guardian of the genome p53 via down regulation of its […]
October 20, 2014

Anti-metastasis therapy: Curcumin, the major componet of turmeric, inhibits invasive motility via down regulation of ICAT (Inhibitor of β-catenin and TCF), 20/October/2014, 16.06

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, L., Anti-metastasis therapy: Curcumin, the major componet of turmeric, inhibits invasive motility via down regulation of ICAT (Inhibitor of β-catenin […]
October 20, 2014

Inerleukin-based therapy for cancer: Resistin suppresses the expression of Notch1 and Notch2 via up regulation of its target gene, 20/October/2014, 6.49 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Inerleukin-based therapy for cancer: Resistin suppresses the expression of Notch1 and Notch2 via up regulation of its target gene, 20/October/2014, 6.49 […]